Ludovic Vallier

Ludovic Vallier is an accomplished researcher in the field of stem cell biology and regenerative therapies. Currently serving as the Einstein Professor for Stem Cells in Regenerative Therapies at the Berlin Institute of Health since June 2022, Vallier specializes in pluripotent stem cells. In addition, Vallier is the Director and Founder of AcuLive Therapeutics Ltd, a pioneering liver therapeutic enterprise established in January 2020 in collaboration with Dr. Marcus Yeo, which utilizes advanced technologies developed at the University of Cambridge. Prior to this, Vallier held the position of Professor of Regenerative Medicine at the University of Cambridge from October 2015 to June 2022. Vallier earned a Doctor of Philosophy (PhD) degree in Cell/Cellular and Molecular Biology from École normale supérieure de Lyon, where studies took place from 1994 to 2001.